This site uses cookies for analytics and advertising. None of them are stored until you agree. Details
UnitedHealth Group Incorporated
AI explains how to read chart patterns, the technical composite score, earnings surprises, and financial metrics. It does not make buy or sell recommendations.
This forecast is a statistical estimate based on historical data and does not guarantee future results. Not investment advice.
| Indicator | Value | Signal |
|---|---|---|
| SMA (5) | 417.24 | Buy |
| SMA (20) | 389.21 | Buy |
| SMA (50) | 388.57 | Buy |
| SMA (200) | 361.03 | Buy |
| EMA (12) | 404.23 | Buy |
| EMA (26) | 394.69 | Buy |
| EMA (50) | 392.66 | Buy |
| WMA (20) | 398.71 | Buy |
| DEMA (20) | 407.94 | Buy |
| TEMA (20) | 419.14 | Sell |
| MACD (12, 26, 9) | macd: 9.54 / signal: 4.47 / histogram: 5.07 | Buy |
| ADX / DMI (14) | adx: 35.47 / pdi: 31.43 / mdi: 9.91 | Buy |
| Ichimoku Cloud (9, 26, 52) | tenkan: 399.67 / kijun: 394.57 / spanA: 390.28 / spanB: 417.63 | Buy |
| Parabolic SAR (0.02, 0.2) | 400.43 | Buy |
| Aroon (25) | up: 96 / down: 36 | Buy |
| Supertrend (10, 3) | supertrend: 385.7 / direction: 1 | Buy |
| Linear Regression Slope (20) | 0.77 | Buy |
| 52-Week High Breakout | high52w: 461.62 / low52w: 255.97 / pctFromHigh: -9.43 | Neutral |
| Cup with Handle (52w) | pivotPrice: 431.68 / handleLow: 362.6 / depthPct: 20.49 | Neutral |
Indicator signals are mechanical calculations based on historical price data and do not guarantee future results. Not investment advice.
Essential valuation, profitability, and balance sheet metrics
Historical quarterly earnings (EPS & surprise) and forward consensus estimates
| Period | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|
| 2025-12 | $2.11 | $2.11 | +0.19% |
| 2026-03 | $7.23 | $6.60 | +9.52% |
| 2026-06 | $6.38 | $4.92 | +29.80% |
| 2026-09 | $4.69 | $4.14 | +13.26% |
| Period | Avg EPS Estimate | EPS Growth Est. | Avg Revenue Estimate | Revenue Growth Est. |
|---|---|---|---|---|
| Current Quarter (0Q) | $2.26 | +7.1% | USD 112.3B | -0.8% |
| Next Quarter (+1Q) | $8.18 | +13.1% | USD 113.7B | +1.8% |
| Current Year (0Y) | $20.59 | +25.9% | USD 449B | +0.3% |
| Next Year (+1Y) | $23.27 | +13.0% | USD 463.6B | +3.3% |
Nearest Expiration: Oct 30, 2026
Based on the nearest-expiry options chain.
Symbol-level short-interest metrics and official market-wide margin statistics
The sources below cover the whole market, not this symbol specifically.
FINRA Margin StatisticsAggregate U.S. margin debt, free credit balances in margin accounts, and free credit balances in cash accounts, published monthly by FINRA across all member firms.Cadence: MonthlyJPX Margin Trading Balances (信用取引残高)Weekly margin trading (buy/sell) balances for listed Japanese equities, published by Japan Exchange Group.Cadence: WeeklyJPX Short Selling Statistics (空売り集計)Daily aggregate short-selling value/ratio statistics for the Japanese equity market, published by Japan Exchange Group.Cadence: DailyAnalyst recommendation distribution and price targets
| Date | Firm | Action | Grade |
|---|---|---|---|
| Oct 22, 2026 | Mizuho | main | Outperform → Outperform |
| Oct 20, 2026 | RBC Capital | main | Outperform → Outperform |
| Oct 16, 2026 | Bernstein | main | Outperform → Outperform |
| Oct 16, 2026 | JP Morgan | main | Overweight → Overweight |
| Oct 15, 2026 | TD Cowen | reit | Hold → Hold |
| Oct 14, 2026 | Piper Sandler | main | Overweight → Overweight |
| Oct 14, 2026 | Barclays | main | Overweight → Overweight |
| Oct 14, 2026 | Baird | main | Neutral → Neutral |
| Oct 9, 2026 | TD Cowen | main | Hold → Hold |
| Jul 21, 2026 | JP Morgan | main | Overweight → Overweight |
Analyst ratings and price targets are aggregated from external data providers and do not constitute investment advice or a recommendation by this site.